EndoAVF | OtherAVF | ||||
---|---|---|---|---|---|
N | Statistic | N | Statistic | p-Value | |
Age (Years) | 16 | 61 (45–67) | 331 | 65 (55–75) | 0.056 |
Gender (% Male) | 16 | 12 (75%) | 331 | 198 (60%) | 0.298 |
Ethnicity | 16 | 330 | 0.393 | ||
White | 7 (44%) | 167 (51%) | |||
Asian | 8 (50%) | 110 (33%) | |||
Black | 1 (6%) | 52 (16%) | |||
Mixed | 0 (0%) | 1 (0%) | |||
Peripheral Vascular Disease | 16 | 0 (0%) | 331 | 36 (11%) | 0.390 |
Diabetes | 16 | 331 | 0.209 | ||
No | 10 (63%) | 198 (60%) | |||
Diet Controlled | 0 (0%) | 27 (8%) | |||
Tablet Controlled | 3 (19%) | 21 (6%) | |||
Insulin | 3 (19%) | 85 (26%) | |||
Heart Problems | 16 | 5 (31%) | 331 | 99 (30%) | 1.000 |
Duration of Haemodialysis (Years) | 16 | 3 (2–4) | 331 | 2 (1–4) | 0.152 |
Duration of Current Access (Years) | 16 | 2 (2–4) | 331 | 2 (1–3) | 0.154 |
Current Access Type | 16 | 328 | N/A | ||
Endovascular AVF | 13 (81%) | 0 (0%) | |||
Brachiocephalic AVF | 2 (13%) | 177 (54%) | |||
Brachiobasilic AVF | 0 (0%) | 35 (11%) | |||
Radiocephalic AVF | 0 (0%) | 116 (35%) | |||
Tunnelled Line | 1 (6%) | 0 (0%) | |||
Any Previous Access** | 16 | 4 (25%) | 331 | 57 (17%) | 0.497 |
Any Radiological Intervention** | 15* | 4 (27%) | 331 | 89 (27%) | 1.000 |
Aneurysmal Fistulas | 15* | 5 (33%) | 331 | 65 (20%) | 0.197 |